Nanoscience Discovery News Today

Scientists at the University of Oxford and the University of Edinburgh have launched a pioneering study that examines how the immune system responds to repeated malaria infections.

Research carried out at the University of Oxford has led development of a blood test to identify Parkinson’s disease

Research carried out at Oxford's Nuffield Department of Clinical Neurosciences has led to the development of a new blood-based test to identify the pathology that triggers Parkinson’s disease before the main symptoms occur. This could allow clinician

Dame Carol Robinson, Dr. Lee's Professor of Chemistry and Director of the Kavli Institute for Nanoscience Discovery at Oxford University, was honoured for her pioneering work in mass spectrometry techniques for over three decades. Her research has tr

An Oxford academic is one of a handful of distinguished scholars worldwide to have been elected a Member of the American Philosophical Society (APS) for 2023.

Oxford, UK-based OMass Therapeutics closed on a $100 million Series B financing round. The round was led by new investors GV (formerly Google Ventures), Northpond Ventures and Sanofi Ventures. Three existing investors also participated: Syncona, Oxford Science Enterprise and Oxford University.